Balasa Dinverno & Foltz Upped Its Johnson & Johnson (JNJ) Stake by $320,364; Amg Funds Position in Akamai Technologies (AKAM) Has Upped by $623,280

December 7, 2017 - By Maria Brooks

Amg Funds Llc increased its stake in Akamai Technologies Inc (AKAM) by 41.49% based on its latest 2017Q2 regulatory filing with the SEC. Amg Funds Llc bought 12,720 shares as the company’s stock declined 24.00% while stock markets rallied. The institutional investor held 43,380 shares of the miscellaneous company at the end of 2017Q2, valued at $2.16M, up from 30,660 at the end of the previous reported quarter. Amg Funds Llc who had been investing in Akamai Technologies Inc for a number of months, seems to be bullish on the $9.45B market cap company. The stock increased 0.22% or $0.12 during the last trading session, reaching $55.89. About 63,848 shares traded. Akamai Technologies, Inc. (NASDAQ:AKAM) has declined 6.51% since December 7, 2016 and is downtrending. It has underperformed by 23.21% the S&P500.

Balasa Dinverno & Foltz Llc increased its stake in Johnson & Johnson (JNJ) by 10% based on its latest 2017Q2 regulatory filing with the SEC. Balasa Dinverno & Foltz Llc bought 2,427 shares as the company’s stock rose 6.85% with the market. The institutional investor held 26,701 shares of the major pharmaceuticals company at the end of 2017Q2, valued at $3.53 million, up from 24,274 at the end of the previous reported quarter. Balasa Dinverno & Foltz Llc who had been investing in Johnson & Johnson for a number of months, seems to be bullish on the $376.65B market cap company. The stock decreased 0.61% or $0.86 during the last trading session, reaching $140.2. About 348,662 shares traded. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since December 7, 2016 and is uptrending. It has underperformed by 4.16% the S&P500.




Investors sentiment decreased to 0.75 in Q2 2017. Its down 0.39, from 1.14 in 2017Q1. It fall, as 75 investors sold AKAM shares while 175 reduced holdings. 54 funds opened positions while 133 raised stakes. 138.74 million shares or 3.56% less from 143.87 million shares in 2017Q1 were reported. Fiduciary invested 0.01% of its portfolio in Akamai Technologies, Inc. (NASDAQ:AKAM). Moreover, Alliancebernstein Limited Partnership has 0.01% invested in Akamai Technologies, Inc. (NASDAQ:AKAM). 229,036 were accumulated by British Columbia Investment Mgmt Corporation. Liberty Mutual Group Asset Mgmt reported 10,577 shares stake. King Luther Management has invested 1.05% in Akamai Technologies, Inc. (NASDAQ:AKAM). Moreover, Allstate has 0.04% invested in Akamai Technologies, Inc. (NASDAQ:AKAM). Bancorporation reported 4,254 shares. Stoneridge Investment Prtnrs Limited Company reported 0.67% stake. Denver Advisors Limited Liability Com holds 0.01% or 5,850 shares in its portfolio. Clifford Swan Invest Counsel stated it has 0.19% in Akamai Technologies, Inc. (NASDAQ:AKAM). Pggm Investments accumulated 492,332 shares or 0.13% of the stock. D E Shaw Communication holds 0.07% or 806,680 shares. Ahl Llp stated it has 0.16% in Akamai Technologies, Inc. (NASDAQ:AKAM). Concert Wealth holds 25,654 shares or 1.24% of its portfolio. Stifel invested in 140,172 shares.

Since June 14, 2017, it had 1 buy, and 1 sale for $113,819 activity. 17,889 shares were sold by SAGAN PAUL, worth $886,042 on Wednesday, June 14.

Amg Funds Llc, which manages about $40.84B and $181.90M US Long portfolio, decreased its stake in Juniper Networks Inc (NYSE:JNPR) by 19,550 shares to 87,328 shares, valued at $2.44 million in 2017Q2, according to the filing. It also reduced its holding in Varian Med Sys Inc (NYSE:VAR) by 8,158 shares in the quarter, leaving it with 19,632 shares, and cut its stake in New York Times Co (NYSE:NYT).

More important recent Akamai Technologies, Inc. (NASDAQ:AKAM) news were published by: Finance.Yahoo.com which released: “Akamai Technologies (AKAM) Up 8.2% Since Earnings Report: Can It Continue?” on November 24, 2017, also Prnewswire.com published article titled: “Akamai Completes Acquisition of Nominum”, Prnewswire.com published: “Akamai Security Experts To Present On Credential Stuffing, Evolution Of HTTP …” on December 04, 2017. More interesting news about Akamai Technologies, Inc. (NASDAQ:AKAM) was released by: Prnewswire.com and their article: “Q3 2017 Akamai State of the Internet / Security Report Reveals Significant …” with publication date: November 28, 2017.

Among 28 analysts covering Akamai Tech (NASDAQ:AKAM), 11 have Buy rating, 2 Sell and 15 Hold. Therefore 39% are positive. Akamai Tech had 72 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Wednesday, April 27 by Craig Hallum. The firm has “Hold” rating given on Monday, July 31 by RBC Capital Markets. On Thursday, December 22 the stock rating was initiated by Guggenheim with “Buy”. Goldman Sachs maintained the shares of AKAM in report on Wednesday, July 27 with “Sell” rating. The company was maintained on Wednesday, January 6 by UBS. As per Friday, August 28, the company rating was maintained by William Blair. The company was maintained on Thursday, October 19 by Robert W. Baird. The rating was maintained by Pacific Crest on Thursday, August 20 with “Overweight”. The stock has “Market Perform” rating by Cowen & Co on Wednesday, October 28. The stock has “Sector Perform” rating by RBC Capital Markets on Thursday, March 24.

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 13 have Buy rating, 5 Sell and 5 Hold. Therefore 57% are positive. Johnson & Johnson had 83 analyst reports since August 7, 2015 according to SRatingsIntel. Cowen & Co maintained Johnson & Johnson (NYSE:JNJ) on Tuesday, August 25 with “Outperform” rating. The stock of Johnson & Johnson (NYSE:JNJ) has “Buy” rating given on Wednesday, April 20 by Argus Research. The company was maintained on Friday, June 2 by BMO Capital Markets. The stock of Johnson & Johnson (NYSE:JNJ) earned “Buy” rating by Wells Fargo on Monday, October 9. The firm has “Buy” rating by Credit Suisse given on Thursday, October 19. On Monday, July 10 the stock rating was maintained by RBC Capital Markets with “Buy”. UBS maintained it with “Buy” rating and $144.0 target in Wednesday, October 19 report. The stock of Johnson & Johnson (NYSE:JNJ) has “Hold” rating given on Monday, September 25 by Citigroup. The stock of Johnson & Johnson (NYSE:JNJ) has “Hold” rating given on Thursday, August 4 by Jefferies. The stock of Johnson & Johnson (NYSE:JNJ) has “Buy” rating given on Monday, October 23 by Citigroup.

Balasa Dinverno & Foltz Llc, which manages about $2.77B and $615.12 million US Long portfolio, decreased its stake in Ishares Russell 1000 Growth (IWF) by 15,816 shares to 1.06 million shares, valued at $126.43 million in 2017Q2, according to the filing. It also reduced its holding in General Motors Corporation (NYSE:GM) by 9,750 shares in the quarter, leaving it with 38,584 shares, and cut its stake in Penumbra Inc.

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Forbes.com which released: “The Outlook For Johnson & Johnson’s Immunology Drug Business” on December 05, 2017, also Seekingalpha.com with their article: “The Right Time To Buy Johnson & Johnson” published on November 17, 2017, Seekingalpha.com published: “Johnson & Johnson: Buy The Pause” on November 29, 2017. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Fiercebiotech.com and their article: “Johnson & Johnson’s JLABS looks east as it lands in Shanghai” published on December 05, 2017 as well as Fool.com‘s news article titled: “Will 2018 Be Johnson & Johnson’s Best Year Yet?” with publication date: December 04, 2017.

Investors sentiment decreased to 0.83 in Q2 2017. Its down 0.03, from 0.86 in 2017Q1. It is negative, as 50 investors sold JNJ shares while 878 reduced holdings. 105 funds opened positions while 667 raised stakes. 1.73 billion shares or 0.03% less from 1.73 billion shares in 2017Q1 were reported. Carroll Associates reported 1.36% of its portfolio in Johnson & Johnson (NYSE:JNJ). Moreover, First Tru has 1.92% invested in Johnson & Johnson (NYSE:JNJ). Nebraska-based Pittenger Anderson has invested 0.67% in Johnson & Johnson (NYSE:JNJ). Orrstown invested in 11,083 shares or 1.6% of the stock. Wellington Shields Limited Liability Corporation holds 51,495 shares or 1.11% of its portfolio. Markel holds 1.72% or 610,800 shares. Hm Management Limited Liability Com holds 10,871 shares or 1.33% of its portfolio. Stearns Fin Group Incorporated stated it has 1.72% of its portfolio in Johnson & Johnson (NYSE:JNJ). 1St Source Retail Bank invested in 1.31% or 114,950 shares. Aberdeen Asset Mgmt Public Limited Uk reported 1.65% of its portfolio in Johnson & Johnson (NYSE:JNJ). 90,783 were reported by Financial Bank Of Nova Scotia Tru. Cape Cod Five Cents Bank holds 2.46% or 117,250 shares. Moreover, Tortoise Invest Limited Com has 0.19% invested in Johnson & Johnson (NYSE:JNJ) for 4,349 shares. United States Steel And Carnegie Pension Fund invested 3.22% of its portfolio in Johnson & Johnson (NYSE:JNJ). 32,203 are owned by Adirondack Tru.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: